Live feed07:18:25·1820dANALYSTRatingvia QuantisnowForte Biosciences downgraded by Chardan Capital Markets with a new price targetByQuantisnow·Wall Street's wire, on your screen.FBRX· Forte Biosciences Inc.Health CareOriginal source